Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress RIO Q4 2025 Earnings EPS Misses Estimates Amid Commodity Headwinds PD Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick RDHL Q2 2022 Earnings Significant EPS Miss Despite Stock Gain PLG Q4 2023 Earnings NarrowerThanExpected Loss Provides a Glimmer of Progress